HIGH WYCOMBE, England, September 8 /PRNewswire/ --

- VELCADE Approved Across all Disease Stages for Broad Spectrum of Patients

Janssen-Cilag / Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced the European Commission's approval of VELCADE in combination with melphalan and prednisone for the treatment of patients with previously untreated multiple myeloma (MM) who are not eligible for high-dose chemotherapy with bone marrow transplant.

In more than 87 countries worldwide, VELCADE monotherapy had already been approved for the treatment of relapsed and / or refractory MM in patients who have received at least one prior therapy.

LAS VEGAS, September 8 /PRNewswire/ --

- Four New Models Feature the Industry's First Wi-Fi Pager and Industry-Specific Functionalities

Ekahau Inc., a leading provider of Wi-Fi-based Real Time Location Systems (RTLS), at RFID World today introduced four new Wi-Fi tags that expand the functionality of its real-time location tracking solutions. The tags, which were designed in response to customer demand in a number of vertical markets, include a personnel badge tag that offers the industry's first two-way Wi-Fi pager capabilities and other solutions for industrial, retail and temperature sensitive environments.

LONDON, September 8 /PRNewswire/ --

- Acquisition Marks the Launch of a Uniquely Commercial Pioneer in Tidal Current Electricity Generation

SAN FRANCISCO, September 8 /PRNewswire/ --

- Live Demo of mobiclip.com Beta for Windows Mobile and Symbian Phones Plus Preview of Live TV on Apple iPhone

Actimagine will demonstrate mobiclip.com, a web-to-mobile platform delivering high-definition video on mobile phones over any wireless network at the September CTIA exhibition.

Sign-up now or at the show for a free account on mobiclip.com to access videos on WinMobile and Symbian phones with just a few clicks. This includes live or on-demand news, sports, movies, entertainment, and more.

Live TV for iPhone will be demonstrated at Actimagine's booth, and made available through mobiclip.com for iPhone(TM) and iTouch(TM) users in the coming weeks.

Infantile spasms are a severe and potentially devastating epilepsy condition affecting children aged typically 4-8 months. Sometimes called West syndrome because it was first described by Dr. William James West in the 1840s, they consist of a sudden jerk followed by stiffening. Each individual seizure usually lasts no more than a second but they occur close together and are most common just after waking up.

In a new study appearing in Epilepsia, researchers have found that the ketogenic diet, a high fat, low carbohydrate diet more traditionally used for intractable childhood epilepsy, is an effective treatment for this condition before using drugs.

The study is the first description of the ketogenic diet as a first-line therapy for infantile spasms.

BALTIMORE, September 8 /PRNewswire/ --

- Offering Achieves Global Recognition As Result of Rigorous Testing

RWD Technologies, a global company that develops and implements organizational performance solutions, today announced the newest version of its comprehensive performance support product that allows staff to collaboratively create, store and manage application simulations and procedural documentation, successfully completed SAP's Premium Qualification process. During the rigorous testing process, RWD uPerform(R) 3.0, met key criteria in a process that focused on 13 categories including usability, security, and functional correctness. The certification covers all RWD uPerform 3.0 versions globally.

REDMOND, Washington, September 8 /PRNewswire/ --

- Leading global brand turns to Windows Embedded NavReady 2009 to quickly bring customers smart, connected, service-oriented portable navigation devices.

Microsoft Corp. today announced that Mio Technology Corp., a leading producer of portable navigation devices (PNDs) with integrated Global Positioning Systems (GPSs), expanded its support of the Windows Embedded offerings and will be shipping its next-generation PNDs on the Windows Embedded NavReady 2009 platform.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

ZURICH, Switzerland, September 8 /PRNewswire/ --

- Preclinical Pharmacokinetic Data to be Presented at the 7th International Symposium on Uveitis in Germany

LONDON, September 8 /PRNewswire/ -- Vagisil(R) are delighted to invite you to The WoW Show - a one-day event, run by Wellbeing of Women, focusing on women's gynaecological health issues at the Royal College of Obstetricians and Gynaecologists.

Bringing together the college's well-respected consultants and leading doctors in the field of gynaecology, The WoW Show gives you the chance to meet the experts and ask the questions you've always wanted to know the answers to.

When: Saturday 20th September 2008, 10.00 am to 4.00 pm Where: The Royal College of Obstetricians and Gynaecologists 27 Sussex Place, London NW1 4SP Visit the Vagisil(R) stand and collect samples. Attend educational seminars to help you dispel the myths surrounding women's health issues.

LONDON, September 8 /PRNewswire/ -- Myconostica, a UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, today announces the launch of a new test to assist medical and scientific professionals identify the two most common causes of fungal pneumonia. The assay, FXGTM: RESP (Asp +), uses Real-Time PCR technology to accurately and rapidly identify infections caused by both Aspergillus and Pneumocystis.

Key Points:

- Fungal pneumonia is the leading cause of infectious death in leukaemia and bone marrow transplant patients and is the most common first manifestation of AIDS.